The oxidative phase of the pentose phosphate pathway including 6-phosphogluconolactonase (Pgl), that converts 6-P-gluconololactone to gluconate-6-P
For reference, key glycolysis, TCA cycle, nucleotide and cell wall biosynthetic pathway intermediates are also shown. Fructose-6-P is fluxed from glycolysis to peptidoglycan (PG), wall teichoic acid (WTA) and lipoteichoic acid (LTA) via UDP-N-acetylglucosamine (UDP-GlcNAc) and UDP-N-acetylmuramic acid (UDP-MurNAc). Fosfomycin (FOS) targets MurA which together with MurB is required for the conversion of UDP-GlcNAc to UDP-MurNAc. Oxacillin (OX) targets the transpeptidase activity of the penicillin binding proteins required for PG crosslinking. The putative gluconate shunt involves the export of 6-phosphogluconolactone, which spontaneously degrades to gluconate before being transported into the cell by the gluconate permease GntP and phosphorylated by the gluconate kinase GntK. Schematic made using Biorender.com.
Publication
Metabolic reprogramming and flux to cell envelope precursors in a pentose phosphate pathway mutant increases MRSA resistance to β-lactam antibiotics. (2023) Merve S. Zeden, et al. bioRxiv. 2023 Mar 7:2023.03.03.530734. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|